Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

KKR's Spectris takeover clears regulatory hurdles in UK, Ireland, Sweden

(Sharecast News) - The proposed acquisition of Spectris by KKR moved a step closer to completion on Wednesday, after receiving several key regulatory clearances. Project Aurora Bidco, the KKR-backed special purpose vehicle, and Spectris announced that authorities in the United Kingdom, Ireland, and Sweden had cleared the takeover.

The Chancellor of the Duchy of Lancaster confirmed that no further action would be taken regarding the acquisition under the UK's National Security and Investment Act.

Additionally, foreign direct investment authorities in both Ireland and Sweden had issued decisions either granting clearance or confirming that the transaction did not require screening under their respective laws.

The companies confirmed that the approvals satisfied several conditions laid out in the Scheme Document circulated to shareholders on 29 July.

With the approvals secured, Spectris said that filing processes in other jurisdictions were progressing in line with expectations.

Subject to the satisfaction of the remaining conditions, the scheme was now expected to become effective in or before the first quarter of 2026.

At 0909 BST, shares in Spectris were up 0.3% at 4,062p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.